Chugaeva UY

References (3)

Title : Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis - Hasan_2025_PLoS.One_20_e0321032
Author(s) : Hasan R , Chugaeva UY , Mohammadian M , Zamanifard S , Mohammadian-Hafshejani A
Ref : PLoS ONE , 20 :e0321032 , 2025
Abstract :
PubMedSearch : Hasan_2025_PLoS.One_20_e0321032
PubMedID: 40323973

Title : Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis - Hasan_2025_PLoS.One_20_e0321032
Author(s) : Hasan R , Chugaeva UY , Mohammadian M , Zamanifard S , Mohammadian-Hafshejani A
Ref : PLoS ONE , 20 :e0321032 , 2025
Abstract :
PubMedSearch : Hasan_2025_PLoS.One_20_e0321032
PubMedID: 40323973

Title : Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis - Hasan_2025_PLoS.One_20_e0321032
Author(s) : Hasan R , Chugaeva UY , Mohammadian M , Zamanifard S , Mohammadian-Hafshejani A
Ref : PLoS ONE , 20 :e0321032 , 2025
Abstract :
PubMedSearch : Hasan_2025_PLoS.One_20_e0321032
PubMedID: 40323973